Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP)

被引：6

作者：

Gomez-Almaguer, David ^{[1
]}

机构：

[1] UANL, Univ Hosp, Serv Hematol, Monterrey, NL, Mexico

来源：

HEMATOLOGY | 2012年 / 17卷

关键词：

Monoclonal antibodies; ITP; Rituximab; Alemtuzumab; Purpura; DOSE RITUXIMAB; ADULTS; EFFICACY; THERAPY; SAFETY;

D O I：

10.1179/102453312X13336169155213

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Immune thrombocytopenic purpura is characterized by antibody-mediated destruction of platelets and suboptimal platelet production. Initially the treatment of ITP includes corticosteroids, IgG-anti-D, and intravenous immunoglobulins. Splenectomy and monoclonal antibodies are usually considered for refractory and chronic ITP patients. There are new data suggesting that early administration of rituximab is important, and this antibody has been used as first-line therapy in adults. In this concise review the role of rituximab and other monoclonal antibodies is analyzed. These agents have the capability of sparing splenectomy and possibly curing the disease in some patients.

引用

页码：S25 / S27

页数：3

共 12 条

[1] Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura [J].

Arnold, Donald M. ;

Dentali, Francesco ;

Crowther, Mark A. ;

Meyer, Ralph M. ;

Cook, Richard J. ;

Sigouin, Christopher ;

Fraser, Graeme A. ;

Lim, Wendy ;

Kelton, John G. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (01) :25-W5

[2] Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders [J].

Dierickx, Daan ;

Delannoy, Andre ;

Saja, Khalid ;

Verhoef, Gregor ;

Provan, Drew .

AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (03) :278-291

[3] Chronic Immune Thrombocytopenia in Adults: Epidemiology and Clinical Presentation [J].

Fogarty, Patrick F. .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (06) :1213-+

[4] Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study [J].

Godeau, Bertrand ;

Porcher, Raphael ;

Fain, Olivier ;

Lefrere, Francois ;

Fenaux, Pierre ;

Cheze, Stephane ;

Vekhoff, Anne ;

Chauveheid, Marie-Paule ;

Stirnemann, Jerome ;

Galicier, Lionel ;

Bourgeois, Emmanuelle ;

Haiat, Stephanie ;

Varet, Bruno ;

Leporrier, Michel ;

Papo, Thomas ;

Khellaf, Mehdi ;

Michel, Marc ;

Bierling, Philippe .

BLOOD, 2008, 112 (04) :999-1004

[5] Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias [J].

Gomez-Almaguer, David ;

Solano-Genesta, Manuel ;

Tarin-Arzaga, Luz ;

Luis Herrera-Garza, Jose ;

Graciela Cantu-Rodriguez, Olga ;

Homero Gutierrez-Aguirre, Cesar ;

Carlos Jaime-Perez, Jose .

BLOOD, 2010, 116 (23) :4783-4785

[6] Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia [J].

Li, Zhenyu ;

Mou, Weiwei ;

Lu, Guang ;

Cao, Jiang ;

He, Xupeng ;

Pan, Xiuying ;

Xu, Kailin .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) :91-98

[7] CAMPATH-1 MONOCLONAL-ANTIBODY THERAPY IN SEVERE REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA [J].

LIM, SH ;

HALE, G ;

MARCUS, RE ;

WALDMANN, H ;

BAGLIN, TP .

BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (03) :542-544

[8]

Marsh JC, 2011, CYTOTHERAPY, V3, P189

[9]

Milani C, 2009, CURR OPIN MOL THER, V11, P200

[10] International consensus report on the investigation and management of primary immune thrombocytopenia [J].

Provan, Drew ;

Stasi, Roberto ;

Newland, Adrian C. ;

Blanchette, Victor S. ;

Bolton-Maggs, Paula ;

Bussel, James B. ;

Chong, Beng H. ;

Cines, Douglas B. ;

Gernsheimer, Terry B. ;

Godeau, Bertrand ;

Grainger, John ;

Greer, Ian ;

Hunt, Beverley J. ;

Imbach, Paul A. ;

Lyons, Gordon ;

McMillan, Robert ;

Rodeghiero, Francesco ;

Sanz, Miguel A. ;

Tarantino, Michael ;

Watson, Shirley ;

Young, Joan ;

Kuter, David J. .

BLOOD, 2010, 115 (02) :168-186

← 1 2 →